FDA Warns Of Liver Damage, Deaths With Intercept Drug
The U.S. Food and Drug Administration warned on Thursday that Intercept Pharmaceuticals Inc.'s liver disease drug Ocaliva is being misdosed in some patients, causing an increased risk of serious liver injury...To view the full article, register now.
Already a subscriber? Click here to view full article